Australia markets closed

Lumos Pharma, Inc. (LUMO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.7436-0.0564 (-2.01%)
As of 10:25AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate-1.18-0.68-2.81-2.01
Low estimate-1.29-1.31-4.84-2.39
High estimate-0.951.29-0.5-1.64
Year ago EPS-0.89-1.09-4.18-2.81
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate300k8.3M8.81M8.64M
Low estimateN/AN/AN/AN/A
High estimate1M40M40M39.14M
Year ago sales691kN/A2.05M8.81M
Sales growth (year/est)-56.60%N/A329.50%-1.90%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-1.12-1.1-1.15-1.15
Actual EPS-0.89-1.09-1.04-1.17
Difference0.230.010.11-0.02
Surprise %20.50%0.90%9.60%-1.70%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-1.18-0.68-2.81-2.01
7 days ago-1.18-0.68-2.81-2.01
30 days ago-1.18-0.68-2.81-2.01
60 days ago-1.01-0.2-3.33-2.62
90 days ago-1.01-0.2-3.33-2.62
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesLUMOIndustrySector(s)S&P 500
Current qtr.-32.60%N/AN/AN/A
Next qtr.37.60%N/AN/AN/A
Current year32.80%N/AN/AN/A
Next year28.50%N/AN/AN/A
Next 5 years (per annum)15.20%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A